Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 237
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06880276 | Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis | ||
| NCT07550465 | Study of QLS1410 in the Treatment of Primary Aldosteronism. | ||
| NCT07416058 | PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC | ||
| NCT03389815 | A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients | ||
| NCT07327697 | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects | ||
| NCT04234594 | Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males. | ||
| NCT07294300 | A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies | ||
| NCT07074236 | Pharmacokinetics and Pharmacodynamics Study | ||
| NCT05860530 | Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers | ||
| NCT05823285 | A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumor Patients | ||
| NCT05055687 | Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD/MAD) | ||
| NCT06823609 | Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors | ||
| NCT06254235 | Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers | ||
| NCT05557565 | A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer | ||
| NCT06232902 | A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers | ||
| NCT05603039 | A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma | ||
| NCT07417917 | QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa | ||
| NCT06686576 | A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer | ||
| NCT04296994 | A Study of QL1706 in Subjects With Advanced Malignant Tumor | ||
| NCT06446388 | Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors | ||
| NCT07173556 | A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer | ||
| NCT07127822 | Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer | ||
| NCT06633718 | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI | ||
| NCT05058105 | Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD) | ||
| NCT05236621 | A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma | ||
| NCT04157257 | An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy | ||
| NCT06261359 | A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma | ||
| NCT06872580 | A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors | ||
| NCT05648669 | A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain | ||
| NCT07432594 | Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer | ||
| NCT05758519 | A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 | ||
| NCT06789796 | a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy. | ||
| NCT07178171 | A Study of QL1706 Combined With Short-Cycle Anthracyclines or Taxanes for the Treatment of Early-Stage TNBC | ||
| NCT07622836 | A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer. | ||
| NCT07453394 | QLS5132 Combination Therapy in Advanced Solid Tumors | ||
| NCT06456528 | QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia | ||
| NCT06742216 | Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory Study | ||
| NCT05830045 | A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors | ||
| NCT04213105 | Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults | ||
| NCT07776080 | Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | ||
| NCT05543343 | Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. | ||
| NCT02908958 | Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency | ||
| NCT05920876 | A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma | ||
| NCT07358858 | A Food Effect Study of QLS1410 in Healthy Chinese Adults | ||
| NCT07272590 | Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors | ||
| NCT04486430 | Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset | ||
| NCT05829616 | A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors | ||
| NCT04527068 | QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer | ||
| NCT05555212 | To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation | ||
| NCT04233151 | QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety |
